JP2004536106A5 - - Google Patents

Download PDF

Info

Publication number
JP2004536106A5
JP2004536106A5 JP2003510062A JP2003510062A JP2004536106A5 JP 2004536106 A5 JP2004536106 A5 JP 2004536106A5 JP 2003510062 A JP2003510062 A JP 2003510062A JP 2003510062 A JP2003510062 A JP 2003510062A JP 2004536106 A5 JP2004536106 A5 JP 2004536106A5
Authority
JP
Japan
Prior art keywords
mycoplasma bovis
vaccine
effective amount
dose
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003510062A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536106A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2002/002514 external-priority patent/WO2003004052A1/en
Publication of JP2004536106A publication Critical patent/JP2004536106A/ja
Publication of JP2004536106A5 publication Critical patent/JP2004536106A5/ja
Pending legal-status Critical Current

Links

JP2003510062A 2001-07-02 2002-06-27 マイコプラズマ・ボビスワクチンおよび動物の肺炎を減少させる方法 Pending JP2004536106A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02
PCT/IB2002/002514 WO2003004052A1 (en) 2001-07-02 2002-06-27 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals

Publications (2)

Publication Number Publication Date
JP2004536106A JP2004536106A (ja) 2004-12-02
JP2004536106A5 true JP2004536106A5 (enExample) 2005-12-08

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003510062A Pending JP2004536106A (ja) 2001-07-02 2002-06-27 マイコプラズマ・ボビスワクチンおよび動物の肺炎を減少させる方法

Country Status (31)

Country Link
US (1) US20030147914A1 (enExample)
EP (1) EP1401488A1 (enExample)
JP (1) JP2004536106A (enExample)
KR (1) KR20040030783A (enExample)
CN (1) CN1522152A (enExample)
AP (1) AP2002002568A0 (enExample)
AR (1) AR036125A1 (enExample)
BG (1) BG108496A (enExample)
BR (1) BR0210798A (enExample)
CA (1) CA2452580A1 (enExample)
CZ (1) CZ20033465A3 (enExample)
EA (1) EA200301324A1 (enExample)
GT (1) GT200200139A (enExample)
HN (1) HN2002000162A (enExample)
HR (1) HRP20031078A2 (enExample)
HU (1) HUP0501188A2 (enExample)
IL (1) IL159516A0 (enExample)
IS (1) IS7078A (enExample)
MA (1) MA27048A1 (enExample)
MX (1) MXPA03011815A (enExample)
NO (1) NO20035767L (enExample)
OA (1) OA12640A (enExample)
PA (1) PA8549801A1 (enExample)
PE (1) PE20030239A1 (enExample)
PL (1) PL373891A1 (enExample)
SK (1) SK15802003A3 (enExample)
TN (1) TNSN03154A1 (enExample)
UY (1) UY27365A1 (enExample)
WO (1) WO2003004052A1 (enExample)
YU (1) YU102103A (enExample)
ZA (1) ZA200309747B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
WO2008030619A2 (en) * 2006-09-07 2008-03-13 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
MX2009001849A (es) 2006-09-11 2009-03-02 Pfizer Prod Inc Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor.
CL2008003202A1 (es) * 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
NZ589981A (en) * 2008-07-03 2012-11-30 Univ Iowa State Res Found Inc Cattle vaccines comprising a disrupted M. bovis bacterium
AU2009309041B2 (en) * 2008-10-31 2016-02-04 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
KR20170077255A (ko) 2009-06-04 2017-07-05 고쿠리츠칸센쇼켄쿠죠 마이코플라즈마 감염증용 백신
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
UA121193C2 (uk) 2012-12-28 2020-04-27 Бьорінгер Інгельхайм Ветмедіка Гмбх Спосіб одержання імуногенної композиції проти мікоплазми
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
CN108135989B (zh) 2015-08-14 2022-08-09 硕腾服务有限责任公司 牛支原体组合物
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Similar Documents

Publication Publication Date Title
JP2004536106A5 (enExample)
ES2368981B1 (es) Vacuna para la enfermedad producida por edwardsiella y la enfermedad producida por estreptococos en peces.
ES2719483T3 (es) Vacuna de combinación CVP/Mycoplasma hyopneumoniae/SRRP
ES2257769T3 (es) Metodo para la preparacion de vacunas multivalentes.
OA12640A (en) Mycoplasma bovis vaccine methods of reducing pneumonia in animals.
Olsen et al. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus
ITMI20111182A1 (it) Vaccino per coronavirus canino
JP2003513935A5 (enExample)
CN101835488A (zh) 轮状病毒的热灭活
CN109806389B (zh) 一种副猪嗜血杆菌三价灭活疫苗及其应用
Collins Pasteurella, Yersinia, and Francisella
JP2009514840A5 (enExample)
CN101559223B (zh) 流脑白百破联合疫苗
JP2011506577A (ja) 魚類ワクチン
Kammer et al. Rabies vaccines: from the past to the 21st century
Waldman et al. Oral immunization of mice with killed Salmonella typhimurium vaccine
JP5470052B2 (ja) 動物の感染症を治療または予防するための免疫原組成物
JP2004508339A5 (enExample)
EP0686039A1 (en) Method of enhancing immune response to oral vaccines
JP2023113631A (ja) クロストリジウム類毒素を含むワクチン
Navruzshoeva et al. Current trends in increasing the biological activity of vaccine strains of Bacillus anthracic
JPH085802B2 (ja) 家禽大腸菌症ワクチン
RU2291709C1 (ru) Способ иммунопрофилактики вирусных респираторных болезней телят
RU2227160C1 (ru) Штамм бактерий leptospira interrogans "митронов" серогруппы canicola для приготовления вакцины
Tan et al. Further studies on feline respiratory virus diseases: 1. Vaccination experiments